Committee Listing

Michael McKee, MD

Grant Garrigues, MD
Andrew Green, MD
Carolyn Hettrich, MD

Mark A. Mighell, MD
Surena Namdari, MD, MSc
Gregory P. Nicholson, MD

John G. Costouros, MD, FACS

John (Jed) Kuhn, MD, MS

Leesa M. Galatz, MD
John E. (Jed) Kuhn, MD, MS
Christopher C. Schmidt, MD

April D. Armstrong, MD, FRCSC
Jonathan P. Braman, MD
John G. Costouros, MD, FACS
Charles L. Getz, MD
Jonathan C. Levy, MD
Thomas (Quin) W. Throckmorton, MD

Julie Y. Bishop, MD
Theodore A. Blaine, MD
Xavier A. Duralde, MD
John C. Macy, MD
Eric T. Ricchetti, MD
Brian R. Wolf, MD, MS

Asheesh Bedi, MD
Brad Bushnell, MD
Alison Cabrera, MD
Matthew Saltzman, MD
Charles Jobin, MD

Scott Steinmann, MD
Emilie Cheung, MD
Peter Chalmers, MD
Xavier Duralde, MD
Mark Frankle, MD
Grant Garrigues, MD
Jason Holcomb, MD
Christopher Klifto, MD
William Levine, MD
Wesley Phipatanakul, MD
Thomas Wright, MD

Carolyn Hettrich, MD
Brian Feeley, MD

Michael Amini, MD, Co-Chair
Justin W. Griffin, MD, Co-Chair
Andrew Sheean, MD, Co-Chair
Albert Lin, MD, Ex-Officio
Eric R. Wagner, MD, MS, Ex-Officio

Joaquin Sanchez-Sotelo, MD, PhD
Scott P. Steinmann, MD

Scott P. Steinmann, MD

Andrew Green, MD, Co-chair
Thomas Throckmorton, MD, Co-chair
Michael Pearl, MD
Anthony Romeo, MD
Robert Tashjian, MD
Matthew Teusink, MD
Michael S. Khazzam, MD
Edwin E. Spencer, MD
Carolyn M. Hettrich, MD
John Sperling, MD
Eric Ricchetti, MD
Jonathan Barlow, MD
Robert Hartzler, MD
Warren Dunn, MD
Shannon Carpenter, MD
Robert Gillespie, MD
Anthony Miniaci, MD
Heinz R. Hoenecke, MD
Peter B. MacDonald, MD, FRCSC
Nikhil N. Verma, MD
Joaquin Sanchez-Sotelo, MD, PhD
John E. (Jed) Kuhn, MD


Joaquin Sanchez-Sotelo, MD, PhD

Brendan M. Patterson, MD, MPH, Chair
Yousif Atwan, MD
Champ Baker, MD
Matthew Budge, MD
Aakash Chauhan, MD
Christopher Loftis
Ryan Cox, MD
Snehal Dalal., MD
Dennis Debernardis, MD
Michael Del Core, MD
Joshua Dines, MD
Joseph Galvin, MD
James Gregory, MD
Ryan Hoffman, MD
Jason Hsu, MD
Christopher Joyce, MD
Utku Kandemir, MD
Samera Kasim, MD
Michael Khazzam, MD
Michael Lee Knudsen, MD
Eitan Kohan, MD
Joseph Labrum ,MD
Joey LaMartina II, MD
Nathan Lanham, MD
Adam Lorenzetti, MD
Kevin Michael Magone, MD
Kevin Magone, MD
David Meister, MD
Kyong Min, MD
Surena Namdari, MD
Wesley Nottage, MD
Jeffrey J Olson, MD
Nathan D. Orvets, MD
Daryl Osbahr, MD
Djuro Petkovic, MD
Miguel Ramirez, MD
Alan Reynolds, MD
Thomas Rogers, MD
John Scanaliato, MD
Mark Schultzel, MD
Austin F. Smith, MD
Daniel Song, MD
Edward Southard, MD
Michael Torchia, MD
Brian C Werner, MD
Benjamin Zmistowski, MD

Asheesh Bedi, MD
Jason Koh, MD
Surena Namdari, MD
Frank Petrigliano, MD

Peter MacDonald, MD
Surena Namdari, MD
Anna K. Quintanilla, MA, CAE

Joaquin Sanchez-Sotelo, MD, PhD, Chair
Julie Bishop, MD

Sara L. Edwards, MD, Chair
Stephanie Muh, MD, Co-chair
Carolyn M. Hettrich, MD, MPH
Daniel Acevedo, MD
Ivan A. Garcia, MD
Armodios Hatzidakis, MD
Havalee Henry, MD
Anand Murthi, MD
Gabriella Ode, MD
Amy Ravindra, MD
Brent Stephens, MD
Katherine B. Vadasdi, MD
Joaquin Sanchez-Sotelo, MD, PhD, Board Liaison 

Rachel M. Frank, MD, Chair
Daniel C. Acevedo, MD, Co-chair
Stephen Brockmeier, MD
Peter N. Chalmers, MD
Wayne Chan, MD
Raymond Chen, MD
Jeffrey “Ryan” Hill, MD
Lewis Martin, MD
Melissa Wright, MD
Robert Gillespie, MD
James D. Kelly II, MD
Julie Bishop, MD

Randall J. Otto, MD, Co-chair
R. Alexander Creighton, MD, Co-chair
Jessica G. Aronowitz, MD
George S. Athwal, MD, FRCSC
Aaron Baessler, MD
Theodore A. Blaine, MD
Michael Boin, MD
Kevin Cronin, MD
Greg Cvetanovich, MD
Daniel E. Davis, MD
Brandon J. Erickson, MD
James M. Gregory, MD
R. Michael Greiwe, MD
Jason C. Ho, MD
Jonathan Hughes, MD
Tyler Johnston, MD
Julia Lee, MD
Shahbaz Malik, MD
Walter B. McClelland Jr, MD
Surena Namdari, MD, MSc
James V. Nepola, MD
Elizabeth M. Nolan, MD
Kaveh Sajadi, MD
Matthew Saltzman, MD
Paul M. Sethi, MD
Kevin P. Shea, MD
Lewis L. Shi, MD
Matthew Smith, MD
Laura Stoll, MD
Jennifer Tangtiphaiboontana, MD
Ivan Wong, MD
Jonathan Wright, MD
Xavier A. Duralde, MD
George S. Athwal, MD, FRCSC

Luke S. Austin, MD, Chair
Mena M. Mesiha, MD, Co-chair
Andrew Jensen, MD
John D. Kelly IV, MD
Todd O’Brien, MD
Joaquin Sanchez-Sotelo, MD, PhD, Board Liaison

Umasuthan (Uma) Srikumaran, MBA, MD, MPH, Chair
Jay Keener, MD, Co-chair
Joseph J. King III, MD
Joseph Choi, MD
Christopher R. Chuinard, MD, MPH
Phani K. Dantuluri, MD
Roberto Ikemoto, MD
Andrew Jensen, MD
Thay Lee, PhD
Mark Mighell, MD
Eloy Tabeayo Alvarez, MD
Thomas (Quin) W. Throckmorton, MD
Edward Yian, MD
Peter MacDonald, MD, FRCSC
Xavier Duralde, MD

Thomas W. Wright, MD, Chair
Shannon R. Carpenter, MD, Co-Chair
Raymond Edward Chen, MD
Aaron M. Chamberlain, MD
David N. Collins, MD
Michael T. Freehill, MD
Brian F. Grogan, MD
Brian K. Lee, MD
Daryl C. Osbahr, MD
Dane H. Salazar, MD
Adam Seidl, MD
J. Michael Wiater, MD
Xavier A. Duralde, MD
George S. Athwal, MD, FRCSC

Julie Bishop, MD, Chair 
Jennifer Lane Vanderbeck, MD, Secretary
Richard Friedman, MD
Abner Ward, MD
Nikhil N. Verma, MD
John (Jed) Kuhn, MD, Ex-Officio

George Athwal, MD, Chair
Graham King, MD, Co-chair
William Levine, MD, Co-chair
Joaquin Sanchez-Sotelo, MD, Co-chair
Joseph Abboud, MD
Emilie Cheung, MD
Patrick Denard, MD
Jonathan Levy, MD
John Sperling, MD
April Armstrong, MD
Peter MacDonald, MD
Brian Wolf, MD
Jeffrey Abrams, MD
Frank Cordasco, MD
Xavier Duralde, MD
Mark Frankle, MD
Felix (Buddy) Savoie, MD
Anthony Romeo, MD

Jeffrey S. Abrams, MD, Co-chair
Bradford O. Parsons, MD, Co-chair
Dave Shukla, MD
Yousif Atwan, MD
Josh Baumfeld, MD
Tyler Brolin
Derek J. Cuff, MD
Joshua S. Dines, MD
Steven D. Levin, MD
Drew V. Miller, MD
Raffy Mirzayan, MD
Brian Shiu, MD
Abner M. Ward, MD, MBA, MA, FACS
Anthony Miniaci, MD

Emilie V. Cheung, MD, Co-Chair
Jason O. Holcomb, MD, Co-Chair
Joseph N. Liu, MD, Secretary
Ryan Bicknell, MD
Nathan Formaini, MD
Kelly G. Kilcoyne, MD
Marc S. Kowalsky, MD
Wesley P. Phipatanakul, MD
Eric T. Ricchetti, MD
Arif Saleem, MD
Brian Shiu, MD
Michael A. Stone, MD
Todd Twiss, MD
Brian R. Waterman, MD
John E. (Jed) Kuhn, MD
Anthony Miniaci, MD

Robert J. Gillespie, MD, Chair
James D. Kelly II, MD, Co-chair
Peter S. Vezeridis, MD
Shariff K. Bishai, MS, DO
Mark T. Dillon, MD
Matthew J. Dubiel, MD
Mohit N. Gilotra, MD
Konrad I. Gruson, MD
Christopher Joyce, MD
Jason R. Kang, MD
Jack E. Kazanjian, DO
Eitan Kohan, MD
Marc S. Kowalsky, MD
Jonathan Levy, MD
Victoria Ann Lilling, MD
Albert Lin, MD
Randall Otto, MD
E. Scott Paxton, MD
Matthew Saltzman, MD
Anshuman Singh, MD
John E. (Jed) Kuhn, MD
Surena Namdari, MD

Carolyn Hettrich, MD, Chair
Joseph J. King, III, MD, Co-chair
Joseph A. Abboud, MD
Michael H. Amini, MD
Jonathan D. Barlow, MD, MS
Akin Cil, MD
Josef K. Eichinger, MD
Mark A. Frankle, MD
Lawrence V. Gulotta, MD
Gabriel (Gabe) Horneff III, MD
Jason E. Hsu, MD
David Kovacevic, MD
Bryan J. Loeffler, MD
Mark E. Morrey, MD
Andrew S. Neviaser, MD
Michael J. O’Brien, MD
Luke S. Oh, MD
Jonathan C. Riboh, MD
Eric T. Ricchetti, MD
Christopher C. Schmidt, MD
Bradley S. Schoch, MD
Peter Simon, PhD

Acromioclavicular Injury Group.  Geoffrey Abrams MD
Controversy exists on the appropriate way to classify and treat acromioclavicular joint injuries.  The Acromioclavicular Injury group is addressing these controversies by finding consensus using the Delphi method, looking at failure mechanisms after surgery and developing outcomes measures and collection strategies to set up outcomes database.

B2 Glenoid Group.  Eric Ricchetti
Management of posterior glenoid bone loss (Walch B2 and B3 glenoids) in patients indicated for shoulder arthroplasty due to end-stage glenohumeral osteoarthritis can be challenging to address at the time of surgery and has been shown to impact clinical outcomes and implant longevity. The distinguishing features of these pathologies, and the factors associated with clinical and radiographic outcomes with different shoulder arthroplasty options in these patients are still not well understood.  Therefore, the mission of the ASES B2 Glenoid Multicenter Research Group is to better understand the defining features of the Walch B2 and B3 glenoid, and to investigate key cohorts of patients with these glenoid morphologies undergoing shoulder arthroplasty to determine the factors related to postoperative clinical and radiographic outcomes at short- and longer-term follow-up. 

Complications of Reverse Arthroplasty Group.  Larry Gulotta
Our mission is to decrease the rate of complications following reverse shoulder arthroplasty through a multicenter initiative.  The first task is to identify the types and rates of various complications using modern implants.  A systematic review of all papers on reverse shoulder arthroplasty published after 2010 has recently been submitted for publication as a two-part series.  In this study, we determined that most major complications have decreased over the years as implants and techniques have improved.  However, acromial and scapular spine stress fractures continue to be a devastating complication that adversely effects the long-term outcome, and for which there are currently limited treatment options.  Therefore, the second task is to specifically study acromial and scapular spine stress fractures.  Under the direction of Andy Jawa, the members of the task force have compiled our retrospective data on this complication to determine patient and implant-related risk factors.  This data has been accepted for presentation at this year’s ASES meeting.  The third task will be to use the information learned from the literature review and retrospective studies in order to devise prospective and interventional studies that can further limit complication after reverse shoulder arthroplasty.

Natural History of Shoulder Arthritis.  Andy Green
Glenohumeral osteoarthritis is a well-recognized condition that causes shoulder pain and dysfunction.  Most of the reported literature on glenohumeral osteoarthritis is focused on the surgical management of advanced stages of the condition.  However, patients present with glenohumeral OA in various stages of pathology and with variable severity of clinical manifestations. Although it is assumed that glenohumeral OA is a progressive disease and condition, there is a paucity of information available regarding the progression of pathology and clinical manifestations. The goal of the Natural History of Glenohumeral Osteoarthritis (NHGOA) multicenter study group is to evaluate the clinical and pathologic manifestations of this condition to provide an understanding of the relationship between the pathoanatomy and clinical manifestations of glenohumeral osteoarthritis and the progression of the condition over time. 

Periprosthetic Joint Infection Group.  Jason Hsu
The ASES Shoulder Periprosthetic Joint Infection (PJI) / Revision Arthroplasty Research group is focused on improving the prevention, diagnosis, and management of infections that occur after shoulder replacement. There currently is little consensus on optimal treatment for potential shoulder PJI. We have established a multicenter REDCap database, and members of this group have been enrolling all consecutive revision arthroplasty patients. A standardized workup for infection has been established. Data from this group will help us optimize diagnosis and treatment of potential infection encountered at revision arthroplasty and will help guide the next iteration of the International Consensus Meeting (ICM) definition for shoulder PJI.

SLAP/Biceps Study Group.  Tiger Li
The SLAP/Biceps Study Group is working to outline and understand the history of the superior labral pathology and the biceps tendon and its anchor and attachment.  Our intent is to define a new description of the terms utilized to describe and classify superior labral and biceps anchor pathology to better direct diagnosis and treatment through the development of a multi-center, prospective, observational study of athletes and active individuals with injuries to the superior labrum and biceps anchor managed with operative and non-operative treatment.  A particular focus will include throwing athletes with the intent to determine the optimal method of diagnosis, classification and treatment through a comprehensive analysis using imaging, functional outcomes and a robust registry capturing specific data focused on return to play. 

MERIT, Massive Cuff Tear Group.  David Kovacevic, Christopher Schmidt
We are a multinational research collaborative whose primary purpose is to better understand, to evaluate, and to investigate the natural history of massive rotator cuff injury and repair.  We will achieve this through an interdisciplinary approach, emphasizing continued development of a prospective observational cohort, establishing, and performing prospective, randomized clinical trials, and improving the tools for measuring clinical outcomes.  Our interdisciplinary team consists of surgeons, scientists, physical therapists, and most importantly, our patients. Collectively, our stakeholder group aims to be the pre-eminent global think tank for improving the lives of patients with massive rotator cuff injury.

Partial Thickness Rotator Cuff Tear Group.  Mike Kim, Jim Leonard
Partial-thickness rotator cuff tears are one of the most common conditions that are seen and treated in the shoulder and elbow surgery field. Our group is seeking to answer some of the challenging yet fundamental questions about this very common conditions. We are specifically looking at the diagnostic performance of imaging modalities, effectiveness of nonoperative treatment, risk factors for failure of nonoperative treatment, and ultimately optimal treatment decision making for individual patients with a partial-thickness rotator cuff tear.

Shoulder Arthritis in the Young Patient Group.  Joseph Abboud
The treatment of glenohumeral osteoarthritis in the young patient remains a challenge for both treating surgeons and patients. Younger patients tend to live more active lifestyles and have longer projected life expectancies, and that can lead to concerns regarding prosthetic longevity and the future need for revision surgery. As such, surgical options for these patients revolve between arthroscopic management and shoulder replacement. The purpose of this study is to determine the survival rate and outcomes of young osteoarthritis patients managed by arthroscopic surgery or by shoulder arthroplasty. The aim is to conduct a multicenter study to follow the patients’ outcomes, extrapolate best treatment strategies, predict complication rates, and derive patient-specific variables that affect prognosis.

Instability with Bone Loss Group.  Brian Lau

The ASES Shoulder Instability Bone Loss committee is studying innovative ways to measure and address glenoid and humeral bone loss. We have evaluated the use of 3D MRI and clinical decision making and hope to develop improved techniques of pre-operative assessment of bone loss. We also hope to develop evidence-based indications for utilization of innovative bone block procedures for glenoid bone loss and treatment algorithms for humeral bone loss.

Proximal Humerus Fracture Group.  Jay King
The overarching goal of the ASES Proximal Humerus Fracture multicenter group is to help improve the algorithm that surgeons can use to treat proximal humerus fractures.  Proximal humerus fractures are one of the most common fractures seen in elderly patients.  While fixation is optimal in young patients, a gold standard treatment algorithm to optimize outcomes in elderly patients does not exist.  The burden of proximal humerus fractures on the aging population is great and improvements in understanding the optimal treatment for these patients is necessary.  The ASES Proximal Humerus Fracture multicenter group is attempting to construct this algorithm starting with identifying the best outcome scores to use, tracking a large cohort of patients treated for proximal humerus fractures to allow for multivariate analysis of the factors associated with good outcomes, and to test this algorithm prospectively.  We also want to add to the current literature on nonoperative treatment of these injuries.  Our hope is that we can preoperatively identify patients who would benefit from certain treatments including nonoperative treatment, internal fixation, and shoulder arthroplasty and also minimize complications associated with these treatments.

Elbow Arthroplasty Group.  Eric Wagner and Michael Gottsalk
In the multicenter TEA group, we have a couple different focuses, including retrospective and national database studies, as well as a prospective randomized controlled trial.  The retrospective and database studies are examining the outcomes of various implants, HO occurrence, and incidence/occurrence of home vs formal physical therapy.  The prospective study is randomizing patients undergoing primary TEA to in situ vs transposition of the ulnar nerve.  We hope these ultimately will serve as a foundation for future intervention related studies to examine common complications after TEA.

Elbow Arthritis in the Young Patient Group.  Gabe Horneff
Elbow arthritis is a difficult problem to address given the inherent limitations and rates of complications and failures seen in total elbow arthroplasty when compared to other forms of joint arthroplasty. For this reason, elbow arthroscopy is often utilized in the younger and more active patient population to give relief of pain, improve range of motion, and attempt to prolong the native anatomy for patients. The goal of this group is to understand the mid- and long-term outcomes of surgical treatment for elbow arthritis. We are currently prospectively examining the results of arthroscopic osteocapsular arthroplasty in young patients under the age of 60 to assess how effective the procedure is in providing relief.  

Elbow Fracture/Dislocation Group.  Akin Cil
The Elbow Fracture/Dislocation group has 15 surgeons from 15 sites all over the USA.  We are studying the best way to manage elbow fractures and dislocations, specifically radial head fractures and coronoid fractures.  We are working on finding agreement for treating elbow injuries and will be enrolling patients in a randomized trial to look at radial head prostheses (smooth versus porous coated) for severe radial head fractures, and also improve understanding and management of coronoid fracture management.

IMOCD Elbow OCD Group.  Mohit Gilotra
Elbow Osteochondritis Dissecans is a common injury in adolescent athletes with a wide range of potential imaging for diagnosis and both nonoperative and operative treatments.  Differences in care vary by patient age, size and location of lesion, sport, and region/continent.  Our goal is to determine the best modalities for diagnosing lesions that are unstable and that may require surgery.  We also want to optimize patient and lesion specific treatment for faster return to play and prevention of long-term arthritis.  Long term we are creating a prospective international registry to answer these challenging questions.  

Elbow Stiffness Group.  Bryan Loeffler
The mission of the elbow stiffness group is to conduct well designed, multicenter studies that will answer the clinical questions of how to best prevent and treat post-traumatic elbow stiffness. Planned studies include comparing operative techniques, postoperative rehab strategies, psychological barriers to improving elbow range of motion, and pharmacologic interventions to improve patient care

Elbow UCL Group.  Luke Oh
The mission of the Elbow UCL Study Group is to study optimal methods of diagnosing and treating ulnar collateral ligament injuries. The studies that we are planning include a 1) Delphi Study, 2) a surgical decision-making study in the management of the ulnar nerve at the time of UCL surgery (either repair or reconstruction), and 3) use of AI deep learning to assist in the diagnosis of UCL partial tears

Xavier A. Duralde, MD, Chair
Gus Mazzocca, MD
Michael McKee, MD
Leesa Galatz, MD
Graham King, MD

Brandon “Brad” D. Bushnell, MBA, MD, Chair
Scott Steinmann, MD, Co-chair
Claudius Jarrett, MD, Secretary
Mina Abdelshahed, MD
Edward Bieber, MD
Akin Cil, MD
Kevin Farmer, MD
Brian Hill, MD
Hafiz Kassam, MD
Adam Khan, MD
John Timothy Moor, MD
Joshua Port, MD
Miguel Ramirez, MD
Alan Reynolds, MD
Vani J. Sabesan, MD
David Weinstein, MD
Melissa A. Wright, MD
Joaquin Sanchez-Sotelo, MD
Anthony Miniaci, MD

John Sperling, MD, Chair
Michael Cusick, MD
Ranjan Gupta, MD
Nady Hamid, MD
Samer Hasan, MD
Jason Koh, MD
Surena Namdari, MD
Paul Sethi, MD
Anup Shah, MD
Jennifer Tangtiphaiboontana, MD
Thomas Throckmorton, MD
Corinne VanBeek, MD
Nikhil Verma, MD
Xavier Duralde, MD, Board Liaison

Michael Khazzam, MD, 2024 Annual Meeting Co-Chair
Carolyn Hettrich, MD, 2024 Annual Meeting Co-Chair
Edwin Spencer, MD, 2024 Annual Meeting Co-Chair
Christopher Klifto, MD, 2024 Specialty Day Co-Chair
Eric Wagner, MD, 2024 Specialty Day Co-Chair
Jarrett Woodmass, MD, 2024 Specialty Day Co-Chair
George Athwal, MD, Ex-Officio
Kevin Plancher, MD, Ex-Officio
Theodore Schlegel, MD, Ex-Officio
Peter MacDonald, MD, Ex-Officio
John (Jed) Kuhn, MD, Ex-Officio

Robert Z. Tashjian, MD, Chair
Peter Simon, PhD, Co-Chair
Benjamin M. Zmistowski, MD, Secretary
William Reuben Aibinder, MD
Michael H. Amini, MD
William Ciccone II, MD
Niloofar Dehghan, MD
Vahid Entezari, MD MMSc
Thomas J. Gill IV, MD
Ranjan Gupta, MD
Tamman Hanna, MD
John Gabriel Horneff, MD
Michael S. Khazzam, MD
H. Mike Kim, MD
Andrew F. Kuntz, MD
Peter Lapner, MD
Xinning Li, MD
Mario Henrique Lobao, MD
C. Benjamin Ma, MD
Nata Parnes, MD
Ryan Rauck, MD
Mark W. Rodosky, MD
Bradley S. Schoch, MD
Ujash Sheth, MD
Karen M. Sutton, MD
Tim L. Uhl, PhD, PT, ATC
C. Thomas Vangsness Jr, MD
Eric R. Wagner, MD, MS
Brian Werner, MD
Ivan Wong, MD
Jarret Murray Woodmass, MD
John E. (Jed) Kuhn, MD
Joaquin Sanchez-Sotelo, MD, PhD

Michael J. O’Brien, MD, Co-Chair
Eric T. Ricchetti, MD – Co-Chair
Charles L. Getz, MD, Ex-Officio
Paul M. Sethi, MD, Ex-Officio


Christopher S. Klifto, MD, Chair
Matthew DiPaola, MD, Co-Chair
Alexander W. Aleem, MD, Secretary
Robert H. Ablove, MD
Peter N. Chalmers, MD
Michael C. Fu, MD, MHS
Nickolas G. Garbis, MD
Galen S. Kam, MD
Christopher M. Kilian, MD
David Kovacevic, MD
Robert Otte, MD
Midhat Patel, MD
Neema Pourtaheri, MD
Brandon Rogalski, MD
Anup A. Shah, MD
James Stensen, MD
Eric Wagner, MD
Matthew P. Willis, MD
George S. Athwal, MD, FRCSC
Peter MacDonald, MD

Vani J. Sabesan, MD (2020)

Grant Garrigues, MD, Chair
Ranjan Gupta, MD
Samer Hasan, MD
Christopher Klifto, MD
Michael Knudsen, MD
Augustus Mazzocca, MD
Julianna Munoz, MD
Scott Steinmann, MD
Thomas Wright, MD
John E. (Jed) Kuhn, MD, Board Liaison
George S. Athwal, MD, FRCSC, Board Liaison

Scroll to Top